Wei-Bang Yu

The development of small-molecule inhibitors targeting CD47.

Jin-jian Lu, Xiuping Chen, Wei-Bang Yu, 2020, Drug discovery today.

INHBB is a novel prognostic biomarker and correlated with immune infiltrates in gastric cancer

Wei-Bang Yu, Guihua He, Suiping Huang, 2021, Frontiers in Genetics.

Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives

Mu-yang Huang, Wei-Bang Yu, Zi-han Ye, 2022, Acta pharmaceutica Sinica. B.

CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer

Yu-Chi Chen, Hong Zhu, Wei-Bang Yu, 2022, Frontiers of Medicine.

Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells.

Jin-jian Lu, Mu-yang Huang, Xiao-ming Jiang, 2020, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Regulation of CD47 expression by interferon-gamma in cancer cells

Jin-jian Lu, Mu-yang Huang, Xiao-ming Jiang, 2021, Translational oncology.